Pascal Minne, Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 365,676 shares at $12.54 ($4.6M) on 2018-06-27, disclosed to the SEC on 2018-06-29.
Open-market purchase of $4.6M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.54 | 125,114 | $1.6M | 34.3% |
| 2 | $12.54 | 125,114 | $1.6M | 34.3% |
| 3 | $12.45 | 57,724 | $719K | 15.7% |
| 4 | $12.45 | 57,724 | $719K | 15.7% |
| Total | $12.51 avg | 365,676 | $4.6M | 100% |
| Filing → |
| LXRX | BUY | 2014-11-26 | $150.7M | — | Filing → |
| WTW | BUY | 2014-08-06 | $5.6M | — | Filing → |